| RheumNow

Nov 5-9, 2020; Perspectives take priority

New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

Dr. Jonathan Kay leads an international panel on the new ACR RA guidelines and other practice-changing abstracts presented at the 2020 ACR annual meeting. Panelists include Dr.Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.

COVID: DMARDs, Steroids, a Vaccine - and how long will this continue? Dr. Winthrop Discusses

Dr. Kevin Winthrop reviews all things COVID-related including abstract L01, steroids and DMARDs, vaccination status - and how long this pandemic will last.

Cardiovascular Risk on MTX in Rheumatoid Arthritis: Dr. Jonathan Kay

Dr. Jonathan Kay reviews several studies that look at the cardiovascular risk of methotrexate in people with rheumatoid arthritis.

How FAST can you go? Dr. Michael Pillinger

Dr. Pillinger weighs in with his view of the FAST trial (abstract L08) presented at ACR 2020.

Cardiovascular Safety for Feboxustat with Dr. Nicola Dalbeth

Auckland's Dr. Dalbeth examines the cardiovascular safety in the FAST trial of feboxustat (abstract L08) presented at the ACR 2020.

Vaccination with Shingrix: Does it work for patients on JAKi?

Dr. Jeffrey Curtis examines abstracts #1997 and #0452 presented at the ACR 2020 annual meeting.

Mid-Meeting Recap: Gout

On Saturday, November 7th, Drs. Cush and Kavanaugh discuss gout studies presented at ACR 2020 with Dr. Michael Pillinger and Dr. Bella Mehta.

Mid-Meeting Recap: Psoriatic Arthritis

On Saturday, November 7th, Drs. Cush and Kavanaugh discuss psoriatic arthritis reports from ACR 2020 with Dr. Eric Ruderman and Dr. Robert Chao.

Mid Meeting Recap: Spondyloarthritis

On Saturday, November 7th, Drs. Cush and Kavanaugh discuss AS/SpA reports from ACR 2020 with Dr. John Reveille and Dr. Olga Petryna.

Dr. Ken Saag - RECIPE Study: MMF with Pegloticase

Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients.

What's New in Calcium Pyrophosphate Disease? with Dr. Michael Pillinger

NYU's Dr. Pillinger talks about Dr. Ann Rosenthal's state of the art talk on calcium pyrophosphate disease at ACR 2020.

Febuxostat bad for the heart? Not so FAST: Dr. Jeffrey Curtis

Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.

Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush

Dr. Cush interviews past ACR president and long-time friend Dr. Stan Cohen on treatment for liver disease in RA patients and new guidelines being released this morning at ACR 2020.

ABCs of RA: Panel Discussion with Dr. Jonathan Kay

They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.